A multicenter, single-arm, phase II study of single-agent vinflunine in the second-line treatment of patients with gastric cancer

Trial Profile

A multicenter, single-arm, phase II study of single-agent vinflunine in the second-line treatment of patients with gastric cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Vinflunine (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 18 Dec 2007 Status changed from suspended to discontinued.
    • 29 Oct 2007 Status changed from recruiting to suspended.
    • 07 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top